• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Drug-coated Balloons in the Neurovascular Setting: A Comprehensive, Systematic Review of Current Use and Indications.神经血管领域中的药物涂层球囊:当前应用与适应症的全面系统综述
Rev Cardiovasc Med. 2022 Apr 2;23(4):128. doi: 10.31083/j.rcm2304128. eCollection 2022 Apr.
2
Clinical outcomes and predictors of restenosis in patients with femoropopliteal artery disease treated using polymer-coated paclitaxel-eluting stents or drug-coated balloons.使用聚合物涂层紫杉醇洗脱支架或药物涂层球囊治疗的股腘动脉疾病患者的临床结局和再狭窄预测因素。
Heart Vessels. 2022 Apr;37(4):555-566. doi: 10.1007/s00380-021-01941-9. Epub 2021 Sep 22.
3
The Efficacy of Drug-Coated Balloons and Drug-Eluting Stents in Infrapopliteal Revascularization: A Meta-analysis.药物涂层球囊和药物洗脱支架在腘下血管重建中的疗效:一项荟萃分析。
J Endovasc Ther. 2024 Jan 6:15266028231222385. doi: 10.1177/15266028231222385.
4
Drug-Coated Balloons for Treatment of Internal Carotid Artery Restenosis After Stenting: A Single-Center Mid-Term Outcome Study.药物涂层球囊治疗支架内颈内动脉再狭窄:单中心中期结果研究。
Cardiovasc Intervent Radiol. 2024 Mar;47(3):291-298. doi: 10.1007/s00270-024-03663-7. Epub 2024 Feb 7.
5
Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.紫杉醇涂层球囊血管成形术治疗股腘外周动脉疾病的安全性。
JACC Cardiovasc Interv. 2019 Dec 23;12(24):2515-2524. doi: 10.1016/j.jcin.2019.08.025. Epub 2019 Sep 28.
6
Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.第二代药物洗脱支架与药物涂层球囊治疗冠状动脉支架内再狭窄的系统评价和荟萃分析
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):285-299. doi: 10.1002/ccd.27359. Epub 2017 Oct 10.
7
Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.紫杉醇涂层球囊联合裸金属支架与雷帕霉素洗脱支架治疗初发病变:一项血管内超声研究。
EuroIntervention. 2012 Aug;8(4):450-5. doi: 10.4244/EIJV8I4A71.
8
Two-year clinical outcomes and predictors of restenosis following the use of polymer-coated paclitaxel-eluting stents or drug-coated balloons in patients with femoropopliteal artery disease.应用聚合物涂层紫杉醇洗脱支架或药物涂层球囊治疗股腘动脉疾病患者的两年临床结果和再狭窄预测因素。
Heart Vessels. 2023 Mar;38(3):429-437. doi: 10.1007/s00380-022-02182-0. Epub 2022 Sep 28.
9
Editor's Choice - Drug Coated Balloon Angioplasty vs. Standard Percutaneous Transluminal Angioplasty in Below the Knee Peripheral Arterial Disease: A Systematic Review and Meta-Analysis.编辑精选 - 药物涂层球囊血管成形术与标准经皮腔内血管成形术治疗膝下外周动脉疾病的比较:系统评价和荟萃分析。
Eur J Vasc Endovasc Surg. 2020 Feb;59(2):265-275. doi: 10.1016/j.ejvs.2019.10.002. Epub 2019 Dec 27.
10
Drug-coated balloons: Technical and clinical progress.药物涂层球囊:技术与临床进展。
Vasc Med. 2020 Dec;25(6):577-587. doi: 10.1177/1358863X20927791. Epub 2020 Jul 7.

本文引用的文献

1
Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial.药物洗脱支架与裸金属支架治疗症状性颅内动脉粥样硬化狭窄程度高的患者比较:一项随机临床试验。
JAMA Neurol. 2022 Feb 1;79(2):176-184. doi: 10.1001/jamaneurol.2021.4804.
2
Treatment of carotid stenosis in asymptomatic, nonoctogenarian, standard risk patients with stenting versus endarterectomy trials.无症状、非 80 岁以上、标准风险的颈动脉狭窄患者支架置入术与颈动脉内膜切除术治疗的临床试验。
J Vasc Surg. 2022 Apr;75(4):1276-1283.e1. doi: 10.1016/j.jvs.2021.10.020. Epub 2021 Oct 22.
3
Treatment of the Carotid In-stent Restenosis: A Systematic Review.颈动脉支架置入术后再狭窄的治疗:一项系统评价。
Front Neurol. 2021 Oct 4;12:748304. doi: 10.3389/fneur.2021.748304. eCollection 2021.
4
Percutaneous Coronary Intervention Vs Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Disease: G-LM Registry.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干病变:G-LM 注册研究。
Curr Probl Cardiol. 2022 Oct;47(10):101002. doi: 10.1016/j.cpcardiol.2021.101002. Epub 2021 Sep 26.
5
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.无症状性颈动脉手术试验 2(ACST-2):颈动脉支架置入术与颈动脉内膜切除术的随机比较
Lancet. 2021 Sep 18;398(10305):1065-1073. doi: 10.1016/S0140-6736(21)01910-3. Epub 2021 Aug 29.
6
Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany.慢性冠状动脉综合征合并左主干病变患者行冠状动脉旁路移植术与支架植入术的对比:来自德国全国注册登记研究的结果。
Clin Res Cardiol. 2022 Jul;111(7):742-749. doi: 10.1007/s00392-021-01931-x. Epub 2021 Aug 28.
7
European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis.欧洲卒中组织关于颈动脉狭窄内膜切除术和支架置入术的指南。
Eur Stroke J. 2021 Jun;6(2):I-XLVII. doi: 10.1177/23969873211012121. Epub 2021 May 11.
8
Drug-Coated Balloons for the Treatment of Symptomatic Intracranial High-Grade Stenosis: A Review of the Current Rationale.药物涂层球囊治疗有症状的颅内高级别狭窄:当前理论依据综述
Front Neurol. 2021 Jul 27;12:692208. doi: 10.3389/fneur.2021.692208. eCollection 2021.
9
Comparison of Drug-Coated Balloons to Bare Metal Stents in the Treatment of Symptomatic Vertebral Artery-Origin Stenosis: A Prospective Randomized Trial.药物涂层球囊与裸金属支架治疗症状性椎动脉起源狭窄的比较:一项前瞻性随机试验。
World Neurosurg. 2021 Oct;154:e689-e697. doi: 10.1016/j.wneu.2021.07.113. Epub 2021 Jul 31.
10
Long-Term Outcome of Enterprise Stenting for Symptomatic ICAS in a High-Volume Stroke Center.大型卒中中心Enterprise支架置入术治疗症状性颅内动脉粥样硬化性狭窄的长期预后
Front Neurol. 2021 Jun 17;12:672662. doi: 10.3389/fneur.2021.672662. eCollection 2021.

神经血管领域中的药物涂层球囊:当前应用与适应症的全面系统综述

Drug-coated Balloons in the Neurovascular Setting: A Comprehensive, Systematic Review of Current Use and Indications.

作者信息

von Gottberg Philipp, Cimpoca Alexandru, Wendl Christina, Cohen José E, Speck Ulrich, Henkes Hans

机构信息

Neuroradiologische Klinik, Klinikum Stuttgart, 70174 Stuttgart, Germany.

Neuroradiologisches Zentrum, Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, 93053 Regensburg, Germany.

出版信息

Rev Cardiovasc Med. 2022 Apr 2;23(4):128. doi: 10.31083/j.rcm2304128. eCollection 2022 Apr.

DOI:10.31083/j.rcm2304128
PMID:39076219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11274058/
Abstract

BACKGROUND

Drug-coated balloons (DCB) are an established tool in the prevention and treatment of coronary and peripheral artery restenosis. The underlying effects of restenosis resemble those in the neurovascular field, yet data on the use of DCB in cervical and intracranial arteries is rare.

METHODS

Medline, and international and major national guidelines and recommendations were systematically searched for data addressing the use of DCB in the neurovascular setting.

RESULTS

Of the 1448 relevant records found in Medline, 166 publications were considered for this review.

CONCLUSIONS

Data on the use of DCB in the neurovascular setting show a possible benefit over preceding alternatives, such as self-expanding stents, and balloon-mounted or drug-eluting stents. Nonetheless, the role of DCB remains under-researched, and publications remain lacking.

摘要

背景

药物涂层球囊(DCB)是预防和治疗冠状动脉及外周动脉再狭窄的既定工具。再狭窄的潜在影响与神经血管领域的相似,但关于DCB在颈内动脉和颅内动脉应用的数据很少。

方法

系统检索Medline以及国际和主要国家指南与建议,以获取有关DCB在神经血管领域应用的数据。

结果

在Medline中找到的1448条相关记录中,166篇出版物被纳入本综述。

结论

关于DCB在神经血管领域应用的数据表明,与先前的替代方法(如自膨式支架、球囊扩张式或药物洗脱支架)相比,DCB可能具有优势。尽管如此,DCB的作用仍研究不足,且相关出版物较少。